Piflufolastat F-18
Ended Awarded Last action
- Contract number
- 36C24422F0090
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 4
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $98,380
Award facts
- Contract value 100% obligated
- $98,449.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$407,574 | |
| Original award | $505,954 |
About this award
This is a delivery order awarded to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. and subsidiary of Lantheus Holdings, Inc. The contract, with a ceiling value of $98,449.96, is for the delivery of PIFLUFOLASTAT F-18, a radiopharmaceutical diagnostic agent used in positron emission tomography (PET) scans to detect and image prostate cancer.
The contract was awarded by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 4 (VISN 4), and is not a set-aside. Progenics Pharmaceuticals is a for-profit organization that specializes in innovative diagnostic imaging agents and targeted therapeutics for oncology. The company has established itself as a critical supplier of specialized medical imaging products to federal healthcare providers, particularly in the cancer diagnostics space, through various federal contract awards. This delivery order is part of the company's larger portfolio of Indefinite Delivery Vehicles (IDVs), including Blanket Purchase Agreements (BPAs) with the VA and Defense Health Agency, which allow for the efficient procurement of radiopharmaceuticals, nuclear medicine supplies, and diagnostic imaging agents by government healthcare providers.
Quick answers
Who was awarded contract 36C24422F0090?
36C24422F0090 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 4 (Veterans Health Administration) on December 2, 2021.
How much is contract 36C24422F0090 worth?
The government has obligated $98,380 on 36C24422F0090. Its current value, with exercised options, is $98,450.
Is contract 36C24422F0090 an order under another contract?
Yes. 36C24422F0090 is a delivery order under 36F79719D0170, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24422F0090 competed?
The extent of competition for 36C24422F0090 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award